Kinetics of hepatitis B surface and envelope antigen and prediction of treatment response to tenofovir in antiretroviral-experienced HIV-hepatitis B virus-infected patients

AIDS
Sarah MaylinKarine Lacombe

Abstract

Hepatitis B surface (HBsAg) and envelope (HBeAg) antigen loss are the primary goals of treating chronic hepatitis B virus (HBV). Although their quantification is useful for other antivirals, such has not been the case with tenofovir disoproxil fumarate (TDF), particularly in HIV infection. Prospective, multicenter, cohort study in 143 antiretroviral-experienced HIV-HBV-co-infected patients initiating TDF. HBsAg (IU/ml) and HBeAg levels (S/CO) were measured every 6 months. HBsAg and HBeAg decline (Δ) were assessed by mixed-effect linear models. Quantification criteria were used to assess predictability of antigen loss with time-dependent receiver operating characteristic curves. After a median follow-up of 30.3 months, cumulative incidence rate of HBsAg loss was 4.0% (n = 4) in the entire study population and HBeAg loss was 21.0% (n = 17) in the 96 HBeAg-positive patients. ΔHBsAg was steady during follow-up (HBeAg-positive: -0.027; HBeAg-negative: -0.017 log(10) IU/ml per month), whereas ΔHBeAg ratio was strongly biphasic (-27.1 S/CO per month before and -6.5 S/CO per month after 18 months). Baseline HBeAg and ΔHBeAg were significantly different in patients harboring precore mutations (P < 0.01), whereas both ΔHBsAg and ΔHBeAg w...Continue Reading

References

Dec 12, 2003·Journal of Virological Methods·Matsuo DeguchiIsa K Mushahwar
Jul 20, 2004·Proceedings of the National Academy of Sciences of the United States of America·Colin A Bill, Jesse Summers
Jan 21, 2006·World Journal of Gastroenterology : WJG·Gerald C KimbiMichael C Kew
Feb 4, 2006·The American Journal of Gastroenterology·Hajo J FlinkUNKNOWN HBV 99-01 Study Group
Jan 30, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anna S F Lok, Brian J McMahon
Jun 29, 2007·Journal of Medical Virology·Jinlin HouNikolai V Naoumov
Dec 7, 2007·The Lancet Infectious Diseases·George V PapatheodoridisAthanasios J Archimandritis
Jan 29, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Michael W FriedMatei Popescu
Jul 23, 2008·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Charlotte LewdenUNKNOWN ANRS EN19 Mortalité Study Group and Mortavic1
Dec 5, 2008·Journal of Hepatology·UNKNOWN European Association For The Study Of The Liver
Dec 31, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Rami MoucariPatrick Marcellin
Apr 2, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Maurizia Rossana BrunettoPatrick Marcellin
Dec 25, 2009·Antiviral Therapy·George SiakallisGeorge Sourvinos
Jan 7, 2010·The Journal of Antimicrobial Chemotherapy·Vincent SorianoUNKNOWN EuroSIDA
Sep 10, 2010·Journal of Clinical Microbiology·Marie GauthierGuy Vernet
Sep 11, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Milan J SonneveldHarry L A Janssen
Oct 12, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Karsten WursthornNikolai V Naoumov

❮ Previous
Next ❯

Citations

Aug 13, 2013·Clinics and Research in Hepatology and Gastroenterology·Stéphane Chevaliez
Aug 21, 2012·PloS One·Jerzy JaroszewiczMarkus Cornberg
Feb 7, 2014·Journal of Acquired Immune Deficiency Syndromes : JAIDS·H Nina KimUNKNOWN Centers for AIDS Research Network of Integrated Clinical Systems
Jan 7, 2015·Liver International : Official Journal of the International Association for the Study of the Liver·Lionel PirothUNKNOWN GERMIVIC Study Group
Mar 13, 2014·Liver International : Official Journal of the International Association for the Study of the Liver·Anders BoydKarine Lacombe
Apr 23, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Anders BoydKarine Lacombe
Mar 8, 2013·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·C S CoffinM J Gill
Feb 2, 2013·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Sarah MaylinKarine Lacombe
Aug 31, 2016·Journal of Hepatology·Markus CornbergHenry Lik-Yuen Chan
Feb 16, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Charles BéguelinUNKNOWN Swiss HIV Cohort Study
Apr 6, 2017·Revista de saúde pública·Ana Luiza de Castro Conde Toscano, Maria Cássia Mendes Corrêa
Dec 23, 2016·The Pediatric Infectious Disease Journal·Linda AurpibulThanyawee Puthanakit
Jun 6, 2018·The American Journal of Tropical Medicine and Hygiene·Abdoulaye SeckYusuke Shimakawa
Mar 7, 2020·Current Opinion in HIV and AIDS·Jennifer Audsley, Joe Sasadeusz
Jul 22, 2020·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jennifer AudsleyJoe Sasadeusz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.